BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33177501)

  • 21. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
    Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
    RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic expression of LINE-1 elements in human tissues.
    Belancio VP; Roy-Engel AM; Pochampally RR; Deininger P
    Nucleic Acids Res; 2010 Jul; 38(12):3909-22. PubMed ID: 20215437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus polymerase restricts LINE-1 mobility.
    Ariumi Y
    Gene; 2023 Jan; 850():146943. PubMed ID: 36198378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Vpr and p21 restrict LINE-1 mobility.
    Kawano K; Doucet AJ; Ueno M; Kariya R; An W; Marzetta F; Kuroki M; Turelli P; Sukegawa S; Okada S; Strebel K; Trono D; Ariumi Y
    Nucleic Acids Res; 2018 Sep; 46(16):8454-8470. PubMed ID: 30085096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enrichment of processed pseudogene transcripts in L1-ribonucleoprotein particles.
    Mandal PK; Ewing AD; Hancks DC; Kazazian HH
    Hum Mol Genet; 2013 Sep; 22(18):3730-48. PubMed ID: 23696454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in understanding the biology of the human mutagen LINE-1.
    Babushok DV; Kazazian HH
    Hum Mutat; 2007 Jun; 28(6):527-39. PubMed ID: 17309057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of Conserved Amino Acids in the C-Terminal Region of LINE-1 ORF2p in Retrotransposition.
    Christian CM; Sokolowski M; deHaro D; Kines KJ; Belancio VP
    Genetics; 2017 Mar; 205(3):1139-1149. PubMed ID: 28100588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 3' Poly(A) Tract Is Required for LINE-1 Retrotransposition.
    Doucet AJ; Wilusz JE; Miyoshi T; Liu Y; Moran JV
    Mol Cell; 2015 Dec; 60(5):728-741. PubMed ID: 26585388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson's Disease Risk and Progression in the PPMI Cohort.
    Pfaff AL; Bubb VJ; Quinn JP; Koks S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-128 represses L1 retrotransposition by binding directly to L1 RNA.
    Hamdorf M; Idica A; Zisoulis DG; Gamelin L; Martin C; Sanders KJ; Pedersen IM
    Nat Struct Mol Biol; 2015 Oct; 22(10):824-31. PubMed ID: 26367248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary conservation of the functional modularity of primate and murine LINE-1 elements.
    Wagstaff BJ; Barnerssoi M; Roy-Engel AM
    PLoS One; 2011 May; 6(5):e19672. PubMed ID: 21572950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent human genomic DNA transduction driven by LINE-1 retrotransposition.
    Pickeral OK; Makałowski W; Boguski MS; Boeke JD
    Genome Res; 2000 Apr; 10(4):411-5. PubMed ID: 10779482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transduction of 3'-flanking sequences is common in L1 retrotransposition.
    Goodier JL; Ostertag EM; Kazazian HH
    Hum Mol Genet; 2000 Mar; 9(4):653-7. PubMed ID: 10699189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Somatic L1 Retrotransposition in Human Cancers.
    Scott EC; Devine SE
    Viruses; 2017 May; 9(6):. PubMed ID: 28561751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.
    Schauer SN; Carreira PE; Shukla R; Gerhardt DJ; Gerdes P; Sanchez-Luque FJ; Nicoli P; Kindlova M; Ghisletti S; Santos AD; Rapoud D; Samuel D; Faivre J; Ewing AD; Richardson SR; Faulkner GJ
    Genome Res; 2018 May; 28(5):639-653. PubMed ID: 29643204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2.
    Aporntewan C; Phokaew C; Piriyapongsa J; Ngamphiw C; Ittiwut C; Tongsima S; Mutirangura A
    PLoS One; 2011 Mar; 6(3):e17934. PubMed ID: 21423624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human L1 retrotransposition: cis preference versus trans complementation.
    Wei W; Gilbert N; Ooi SL; Lawler JF; Ostertag EM; Kazazian HH; Boeke JD; Moran JV
    Mol Cell Biol; 2001 Feb; 21(4):1429-39. PubMed ID: 11158327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide de novo L1 Retrotransposition Connects Endonuclease Activity with Replication.
    Flasch DA; Macia Á; Sánchez L; Ljungman M; Heras SR; García-Pérez JL; Wilson TE; Moran JV
    Cell; 2019 May; 177(4):837-851.e28. PubMed ID: 30955886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic heterogeneity in LINE-1 retrotransposition activity.
    Lutz SM; Vincent BJ; Kazazian HH; Batzer MA; Moran JV
    Am J Hum Genet; 2003 Dec; 73(6):1431-7. PubMed ID: 14610717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.
    Ma H; Liu B; Wang S; Liu J
    Cell Biochem Funct; 2016 Dec; 34(8):613-619. PubMed ID: 27862077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.